HealthEquity, Inc. (NASDAQ:HQY) Receives Average Rating of "Buy" from Analysts

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) has been given a consensus recommendation of "Buy" by the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $118.09.

A number of research firms recently weighed in on HQY. Royal Bank Of Canada raised their target price on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. Raymond James Financial upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. The Goldman Sachs Group upped their target price on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a report on Wednesday, June 4th. Finally, KeyCorp decreased their price target on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th.

HealthEquity Stock Down 1.9%

HQY traded down $1.97 during trading on Friday, hitting $100.92. The company had a trading volume of 711,304 shares, compared to its average volume of 856,504. The company has a market capitalization of $8.73 billion, a PE ratio of 73.71, a PEG ratio of 1.61 and a beta of 0.49. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. HealthEquity has a one year low of $65.01 and a one year high of $116.65. The firm's 50-day moving average price is $98.89 and its 200 day moving average price is $98.12.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.16. The firm had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter last year, the business posted $0.80 EPS. As a group, equities analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. The trade was a 43.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director owned 84,969 shares in the company, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 304,581 shares of company stock valued at $33,664,018. Company insiders own 1.50% of the company's stock.

Institutional Investors Weigh In On HealthEquity

Hedge funds and other institutional investors have recently made changes to their positions in the business. Transce3nd LLC bought a new position in HealthEquity during the 4th quarter worth $29,000. WPG Advisers LLC acquired a new stake in shares of HealthEquity during the 1st quarter worth $28,000. Versant Capital Management Inc acquired a new stake in shares of HealthEquity during the 1st quarter worth $28,000. Smartleaf Asset Management LLC increased its position in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ raised its stake in HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after purchasing an additional 445 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.